The Medical Minute: Thyroid cancer on the rise

September 21, 2012
The Medical Minute: Thyroid cancer on the rise
Leah Cream, a Penn State Hershey oncologist, talks about how she got the upper hand on thyroid cancer.

September is Thyroid Cancer Awareness Month. With cases on the rise locally, nationally and globally, Dr. David Goldenberg, director of Head and Neck Surgery at Penn State Hershey Medical Center, hopes people will become more mindful of the disease.

"In 1980 it was the 20th most common cancer in the United States. Now it's the eighth," Goldenberg said. "It is the fastest growing new cancer amongst women. What we don't know and don't understand is why."

The is a butterfly shaped gland located on the front of the neck that produces hormones that help the body control metabolism. The prognosis overall for thyroid cancer is very good: Most patients go on and lead a full, healthy life with thyroid replacement therapy, Goldenberg said. While anaplastic and equally rare medullary thyroid cancers both carry a , follicular and papillary thyroid cancers are much more easily treated. is the most common type, encompassing 80 to 85 percent of all thyroid cancer.

According to Goldenberg, there are no signs or symptoms until "very, very late in the game." The vast majority of thyroid cancers are found when a physician is doing a physical exam on a patient or when a patient is undergoing testing for a completely different reason. Nodules (growths or ) are found on the thyroid, and that prompts further testing.

" are extremely common, and only one out of 20 of these nodules will actually be a cancerous nodule," he said.

While there are no recommendations for routine screenings of the general population, Goldenberg said people exposed to radiation at a very early age or with a history of thyroid cancer are more at risk.

"Those patients certainly should have at the very least a and perhaps an ultrasound as well," he said. "And they probably should have a more thorough investigation."

Treatment for thyroid cancer is typically surgical in the form of a thyroidectomy, or removal of the thyroid. In addition, patients are given radioactive iodine in the form of a liquid or a pill to complete treatment.

It is not uncommon for thyroid cancer survivors to have a recurrence. Up to 25 percent of patients may have a recurrence of papillary thyroid cancer after initial treatment.

"The recurrence typically happens in the neck and fortunately does not negatively impact the patient's prognosis. In short, even if the patient has a recurrence of papillary thyroid cancer, chances are they'll do just fine," Goldenberg said.

Papillary thyroid cancer sometimes spreads to the lymph nodes in the neck. Those patients undergo a neck dissection, which is the removal of a chain of lymph nodes along the jugular vein in the neck.

To pinpoint what's caused the increase in thyroid cancer cases, researchers are now looking at risk factors including radon, obesity and diabetes as part of their ongoing studies. Looking at the effects of certain types of chemotherapy to treat and possibly cure anaplastic thyroid cancer, for which there currently are no effective treatments, is also part of their investigation.

Even with the majority of positive outcomes, Goldenberg urges his peers in the oncology community as well as government agencies that allot funding to research to recognize thyroid cancer and its increasing number of cases.

" is on the rise," he said. "The rates are soaring, and the reasons are not really very clear to us. So there needs to be more of an interest and more funding because we'll only be hearing more about this type of cancer as time goes on."

Explore further: Removal of lymph nodes during surgery for thyroid cancer may be beneficial

Related Stories

Removal of lymph nodes during surgery for thyroid cancer may be beneficial

December 20, 2011
Papillary thyroid cancer accounts for the majority of all thyroid malignancies, which primarily impact women. A new study indicates that routinely removing lymph nodes in the neck in these cancer patients may help prevent ...

BRAF addiction of thyroid cancers makes them therapeutically vulnerable

November 21, 2011
Papillary carcinoma is the most common form of thyroid cancer. Approximately one quarter of these carcinomas have mutations in the BRAF gene. The prevalence of such mutations is even greater in high-grade carcinomas, particularly ...

Have no fear: Most cases of thyroid cancer do not affect survival

June 11, 2012
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...

African-Americans with thyroid cancer fare worse than whites

June 21, 2011
African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis -- and are more likely to die from it, according to a new study.

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

New study reveals breast cancer cells recycle their own ammonia waste as fuel

October 19, 2017
Breast cancer cells recycle ammonia, a waste byproduct of cell metabolism, and use it as a source of nitrogen to fuel tumor growth, report scientists from Harvard Medical School in the journal Science.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.